Skip to main content

Table 2 Clinical characterization assessments

From: Discovering biomarkers for antidepressant response: protocol from the Canadian biomarker integration network in depression (CAN-BIND) and clinical characteristics of the first patient cohort

Clinician-Administered Assessments
 Montgomery Asberg Depression Rating Scale (MADRS)
 Young Mania Rating Scale (YMRS)
 Clinical Global Impression (CGI)
 Depression Inventory Development (DID) Interview
 Toronto Side Effects Scale (TSES)
 Sexual Side Effects Questionnaire (SexFX)
 Childhood Experience of Care and Abuse (CECA)
 Life Events and Difficulties Schedule (LEDS)
 CNS Vital Signs (CNS-VS) computerized neuropsychological test battery
 National Adult Reading Test (NART)
Self-Report Assessments
 Quick Inventory of Depressive Symptomatology, Self-Report (QIDS-SR)
 Generalized Anxiety Disorder 7-item scale (GAD-7)
 Hypomania Check-List (HCL-32)
 Brief Pain Inventory (BPI)
 Sheehan Disability Scale (SDS)
 Lam Employment Absence and Productivity Scale (LEAPS)
 Quality of Life, Enjoyment and Satisfaction Questionnaire (Q-LES-Q)
 World Health Organization Quality of Life Assessment (WHOQoL-BREF)
 Pittsburgh Sleep Quality Index (PSQI)
 Seasonal Pattern Assessment Questionnaire (SPAQ)
 Biological Rhythm Interview of Assessment in Neuropsychiatry (BRIAN)
 Dimensional Anhedonia Rating Scale (DARS)
 Snaith-Hamilton Pleasure Scale (SHAPS)
 Behavioural Inhibition/Behavioural Activation System (BIS/BAS)
 NEO Five-Factor Inventory (NEO-FFI)
 Experiences in Close Relationships (ECR-R) questionnaire
 List of Threatening Experiences (LTE)
 International Physical Activity Questionnaire (IPAQ)
 Brief Diet Questionnaire